Acyldepsipeptide Analogues: A Future Generation Antibiotics for Tuberculosis Treatment
Acyldepsipeptides (ADEPs) are a new class of emerging antimicrobial peptides (AMPs), which are currently explored for treatment of pathogenic infections, including tuberculosis (TB). These cyclic hydrophobic peptides have a unique bacterial target to the conventional anti-TB drugs, and present a the...
Main Authors: | , , , |
---|---|
Format: | Article |
Jezik: | English |
Izdano: |
MDPI AG
2022-09-01
|
Serija: | Pharmaceutics |
Teme: | |
Online dostop: | https://www.mdpi.com/1999-4923/14/9/1956 |